Community-acquired MRSA: A notable adversary

Southern Medical Journal

Volumn 98, Issue 11, 2005, Pages 1061-1062

  Francis, John S ^a   Carroll, Karen ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LINEZOLID; MEMBRANE PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS TOXIN; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; EDITORIAL; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SKIN INFECTION; SOFT TISSUE INFECTION; TOXIN ANALYSIS;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; LEUKOCIDINS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 28844469858     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000184802.96994.62     Document Type: Editorial

References (20)

1. Clancy MJ, Graepler A, Breese PE, et al. The widespread emergence of methicillinresistance in community-acquired Staphylococcus aureus infections in Denver. South Med J 2005;98:1069-1075.
2. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin- resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598.
3. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community- associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital. Pediatr Infect Dis J 2004;23: 619-624.
4. Carleton HA, Diep BA, Charlebois ED, et al. Community-adapted methicillin- resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004;190: 1730-1738.
5. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin- resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-984.
6. Robinson DA, Kearns AM, Holmes A, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 2005;365:1256-1258.
7. Konig B, Prevost G, Piemont Y, et al. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995;171:607-613.
8. Ward PD, Turner WH. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect Immun 1980;27: 393-397.
9. Liassine N, Auckenthaler R, Descombes MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 2004;42:825-828.
10. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community acquired MRSA. Lancet 2002;359: 1819-1827.
11. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-1453.
12. Sattler CA, Mason Jr., EO, Kaplan, SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002;21:910-916.
13. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-1205.
14. Gillet Y, Issartel B, Banhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002;359:753-759.
15. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004;39:971-979.
16. Wunderink RG, Rello J, Cammarata SK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124:1789-1797.
17. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003;37:1257-1260.
18. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352: 1436-1444.
19. Ruiz ME, Yohannes S, Wladyka CG. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2005;352:1488-1489.
20. Kravitz GR, Dries DJ, Peterson ML, et al. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005;40:941-947.